Evotec AG: Results of Pre-Clinical Studies Lead to Reduction in Revenues, Nevertheless Profitable and More Than EURO 90 M Cash for 2013 Confirmed
December 13, 2013 04:31 ET
|
Evotec AG
HAMBURG, Germany, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that it is adjusting its guidance regarding...
Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim
December 10, 2013 01:46 ET
|
Evotec AG
HAMBURG, Germany, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...
Evotec AG Reports First Nine Months 2013 Results
November 12, 2013 01:56 ET
|
Evotec AG
DRIVING INNOVATION AND CAPITAL EFFICIENCY WITH STRONG LIQUIDITY POSITION
POSITIVE NEWS FLOW CHARACTERISES THIRD QUARTER 2013
HAMBURG, Germany, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Evotec AG...
Evotec Announces TargetAD Collaboration With Johnson & Johnson Innovation to Identify and Develop Novel Alzheimer's Disease Therapies
November 08, 2013 01:28 ET
|
Evotec AG
Collaborative effort will explore genes dysregulated in Alzheimer's disease patients to identify new targets for drug discovery and development
HAMBURG, Germany, Nov. 8, 2013 (GLOBE NEWSWIRE)...
Evotec to Report Results for the First Nine Months of 2013 on 12 November 2013
November 06, 2013 04:00 ET
|
Evotec AG
HAMBURG, Germany, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first nine months of 2013 on Tuesday, 12 November...
Evotec and The Leukemia & Lymphoma Society Enter Into a Strategic Research Collaboration
November 05, 2013 01:37 ET
|
Evotec AG
HAMBURG, Germany, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that it has entered into an integrated research collaboration with The...
Evotec Achieves First Milestones in Multi-Target Deal With UCB
October 28, 2013 02:44 ET
|
Evotec AG
HAMBURG, Germany, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) today announced that it has achieved first milestones in its multi-year, multi-target...
Evotec Enters Integrated Alliance With AstraZeneca in Kidney Disease
October 21, 2013 01:47 ET
|
Evotec AG
HAMBURG, Germany, Oct. 21, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) today announced that it has signed an agreement with AstraZeneca in the field of kidney...
Evotec to Hold R&D Day 2013
October 16, 2013 08:09 ET
|
Evotec AG
HAMBURG, Germany, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) announced today that its R&D Day 2013 will take place on 22 October 2013 in New York...
Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim
October 15, 2013 01:36 ET
|
Evotec AG
HAMBURG, Germany, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...